Masimo | MASI - Current Assets

Stock Price
178.63
Daily Change
-0.08 -0.04%
Monthly
0.30%
Yearly
9.09%
Q2 Forecast
174.81

Masimo reported $926M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Accuray USD 303.6M 13.86M Sep/2025
Align Technology USD 2.62B 82.47M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 358.08M 20.58M Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Avanos Medical USD 355.4M 4M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.74B 380M Dec/2025
General Electric Aerospace USD 40.36B 235M Mar/2026
Globus Medical USD 2.13B 201.25M Dec/2025
Haemonetics USD 943.67M 43.99M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
Intuitive Surgical USD 11.52B 881.5M Mar/2026
Masimo USD 926M 122.3M Dec/2025
Medtronic USD 24.07B 75M Dec/2025
Orthofix International USD 416.85M 22.68M Dec/2025
Owens Minor USD 547.87M 1.58B Dec/2025
ResMed USD 3.82B 193.06M Dec/2025
Steris USD 2.29B 179.9M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025